Physiological metrics captured via wearable devices may help identify and predict flares in inflammatory bowel disease, ...

For more than a decade, Michelle Hobson endured extreme fatigue, excruciating abdominal pain, and repeated hospital visits.

Dual biologic therapy may serve as a suitable treatment choice for patients with IBD who have not responded to current therapies.

BERLIN — Gut microbial biomarkers identified using machine learning can differentiate patients with inflammatory bowel disease (IBD) from healthy control individuals, according to a study ...

Better cardiovascular safety and lower risk of all-cause mortality was observed among older adult patients with IBD who received ustekinumab vs vedolizumab.